# 131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

> **NCT01370330** · — · AVAILABLE · sponsor: **Kieuhoa Vo**

## Conditions studied

- Neuroblastoma

## Interventions

- **DRUG:** Metaiodobenzylguanidine (MIBG)

## Key facts

- **NCT ID:** NCT01370330
- **Lead sponsor:** Kieuhoa Vo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01370330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01370330, "131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01370330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*